These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

145 related items for PubMed ID: 10362332

  • 21. Randomized, placebo-controlled trial of Saforis for prevention and treatment of oral mucositis in breast cancer patients receiving anthracycline-based chemotherapy.
    Peterson DE, Jones JB, Petit RG.
    Cancer; 2007 Jan 15; 109(2):322-31. PubMed ID: 17154160
    [Abstract] [Full Text] [Related]

  • 22. Double-blinded, placebo-controlled trial on intravenous L-alanyl-L-glutamine in the incidence of oral mucositis following chemoradiotherapy in patients with head-and-neck cancer.
    Cerchietti LC, Navigante AH, Lutteral MA, Castro MA, Kirchuk R, Bonomi M, Cabalar ME, Roth B, Negretti G, Sheinker B, Uchima P.
    Int J Radiat Oncol Biol Phys; 2006 Aug 01; 65(5):1330-7. PubMed ID: 16765532
    [Abstract] [Full Text] [Related]

  • 23. Prophylaxis with GM-CSF mouthwashes does not reduce frequency and duration of severe oral mucositis in patients with solid tumors undergoing high-dose chemotherapy with autologous peripheral blood stem cell transplantation rescue: a double blind, randomized, placebo-controlled study.
    Dazzi C, Cariello A, Giovanis P, Monti M, Vertogen B, Leoni M, Tienghi A, Turci D, Rosti G, Nanni O, Rondoni C, Marangolo M.
    Ann Oncol; 2003 Apr 01; 14(4):559-63. PubMed ID: 12649101
    [Abstract] [Full Text] [Related]

  • 24. Irsogladine maleate reduces the incidence of fluorouracil-based chemotherapy-induced oral mucositis.
    Nomura M, Kamata M, Kojima H, Hayashi K, Sawada S.
    Ann Oncol; 2013 Apr 01; 24(4):1062-6. PubMed ID: 23152361
    [Abstract] [Full Text] [Related]

  • 25. Double-blind, placebo-controlled, randomized phase II study of TJ-14 (Hangeshashinto) for infusional fluorinated-pyrimidine-based colorectal cancer chemotherapy-induced oral mucositis.
    Matsuda C, Munemoto Y, Mishima H, Nagata N, Oshiro M, Kataoka M, Sakamoto J, Aoyama T, Morita S, Kono T.
    Cancer Chemother Pharmacol; 2015 Jul 01; 76(1):97-103. PubMed ID: 25983022
    [Abstract] [Full Text] [Related]

  • 26. A double-blind, randomized, placebo-controlled, crossover trial of pentoxifylline for the prevention of chemotherapy-induced oral mucositis.
    Verdi CJ, Garewal HS, Koenig LM, Vaughn B, Burkhead T.
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 1995 Jul 01; 80(1):36-42. PubMed ID: 7552860
    [Abstract] [Full Text] [Related]

  • 27. A double-blind randomized placebo-controlled study of oral glutamine in the prevention of mucositis in children undergoing hematopoietic stem cell transplantation: a pediatric blood and marrow transplant consortium study.
    Aquino VM, Harvey AR, Garvin JH, Godder KT, Nieder ML, Adams RH, Jackson GB, Sandler ES.
    Bone Marrow Transplant; 2005 Oct 01; 36(7):611-6. PubMed ID: 16086046
    [Abstract] [Full Text] [Related]

  • 28. Glutamine and alanyl-glutamine accelerate the recovery from 5-fluorouracil-induced experimental oral mucositis in hamster.
    Leitão RF, Ribeiro RA, Lira AM, Silva LR, Bellaguarda EA, Macedo FD, Sousa RB, Brito GA.
    Cancer Chemother Pharmacol; 2008 Feb 01; 61(2):215-22. PubMed ID: 17426972
    [Abstract] [Full Text] [Related]

  • 29. Phase I study of eniluracil, a dihydropyrimidine dehydrogenase inactivator, and oral 5-fluorouracil with radiation therapy in patients with recurrent or advanced head and neck cancer.
    Humerickhouse RA, Dolan ME, Haraf DJ, Brockstein B, Stenson K, Kies M, Sulzen L, Ratain MJ, Vokes EE.
    Clin Cancer Res; 1999 Feb 01; 5(2):291-8. PubMed ID: 10037177
    [Abstract] [Full Text] [Related]

  • 30. Inhibition of fluorouracil-induced stomatitis by oral cryotherapy.
    Mahood DJ, Dose AM, Loprinzi CL, Veeder MH, Athmann LM, Therneau TM, Sorensen JM, Gainey DK, Mailliard JA, Gusa NL.
    J Clin Oncol; 1991 Mar 01; 9(3):449-52. PubMed ID: 1999715
    [Abstract] [Full Text] [Related]

  • 31. A morphometric study of the protective effect of cryotherapy on oral mucositis in cancer patients treated with 5-fluorouracil.
    Turkeli M, Aldemir MN, Bingol F, Dogan C, Kara A.
    Biotech Histochem; 2016 Oct 01; 91(7):465-471. PubMed ID: 27644112
    [Abstract] [Full Text] [Related]

  • 32. [Elental prevented and reduced oral mucositis during chemotherapy in patients esophageal cancer].
    Fukui T, Itoh Y, Orihara M, Yoshizawa K, Takeda H, Kawada S, Yoshioka T.
    Gan To Kagaku Ryoho; 2011 Dec 01; 38(13):2597-601. PubMed ID: 22189225
    [Abstract] [Full Text] [Related]

  • 33. Effect of prophylactic sucralfate suspension on stomatitis induced by cancer chemotherapy. A randomized, double-blind cross-over study.
    Pfeiffer P, Madsen EL, Hansen O, May O.
    Acta Oncol; 1990 Dec 01; 29(2):171-3. PubMed ID: 1692228
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Risk factors associated with mucositis in cancer patients receiving 5-fluorouracil.
    McCarthy GM, Awde JD, Ghandi H, Vincent M, Kocha WI.
    Oral Oncol; 1998 Nov 01; 34(6):484-90. PubMed ID: 9930359
    [Abstract] [Full Text] [Related]

  • 36. Transforming growth factor-beta 3 mediated modulation of cell cycling and attenuation of 5-fluorouracil induced oral mucositis.
    Sonis ST, Van Vugt AG, Brien JP, Muska AD, Bruskin AM, Rose A, Haley JD.
    Oral Oncol; 1997 Jan 01; 33(1):47-54. PubMed ID: 9192553
    [Abstract] [Full Text] [Related]

  • 37. Reduction of oral toxicity of 5-fluorouracil by allopurinol mouthwashes.
    Tsavaris N, Caragiauris P, Kosmidis P.
    Eur J Surg Oncol; 1988 Oct 01; 14(5):405-6. PubMed ID: 3181443
    [Abstract] [Full Text] [Related]

  • 38. [High incidence-rate of oral mucositis in breast cancer patients receiving anthracycline-based chemotherapy (FEC100)].
    Fukazawa M, Kawaguchi H, Shigematsu H, Koga C, Mori E, Nishimura S, Nakamura Y, Satou S, Sawamura K, Kashiwaba K, Ohno S.
    Gan To Kagaku Ryoho; 2012 Mar 01; 39(3):395-8. PubMed ID: 22421766
    [Abstract] [Full Text] [Related]

  • 39. Uridine allows dose escalation of 5-fluorouracil when given with N-phosphonacetyl-L-aspartate, methotrexate, and leucovorin.
    Seiter K, Kemeny N, Martin D, Schneider A, Williams L, Colofiore J, Sawyer R.
    Cancer; 1993 Mar 01; 71(5):1875-81. PubMed ID: 8448752
    [Abstract] [Full Text] [Related]

  • 40. Biochemical modulation of fluorouracil: comparison of methotrexate, folinic acid, and fluorouracil versus folinic acid and fluorouracil in advanced colorectal cancer: a randomized trial.
    Polyzos A, Tsavaris N, Giannopoulos A, Bacoyiannis C, Papadimas V, Kalahanis N, Karatzas G, Kosmas C, Sakelaropoulos N, Archimandritis A, Papachristodoulou A, Kosmidis P.
    Cancer Chemother Pharmacol; 1996 Mar 01; 38(3):292-7. PubMed ID: 8646806
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.